Identification of patients with relapsing multiple sclerosis eligible for high-efficacy therapies.

Volume: 11, Issue: 3, Pages: 251 - 261
Published: May 10, 2021
Abstract
Relapsing multiple sclerosis (RMS) presents a highly variable clinical evolution among patients, and its management should be personalized. Although there is no cure at present, effective disease-modifying therapies (DMTs) are available. Selection of the most appropriate DMT for each patient is influenced by several clinical, radiological and demographic aspects as well as personal preferences that, at times, are not covered in the regulatory...
Paper Details
Title
Identification of patients with relapsing multiple sclerosis eligible for high-efficacy therapies.
Published Date
May 10, 2021
Volume
11
Issue
3
Pages
251 - 261
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.